ARSA and metachromatic leukodystrophy: Enzyme replacement therapy (ERT) with recombinant human arylsulfatase A (rhASA) has been tested in two phase 1/2 open-label trials in subjects with MLD, one with intravenous (IV) delivery and one with intrathecal (IT) delivery [44,45].